JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on August 8, 2003
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
278/32/29487    most recent
M213251200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donahue, S. L.
Right arrow Articles by Campbell, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donahue, S. L.
Right arrow Articles by Campbell, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print May 14, 2003
J. Biol. Chem, 10.1074/jbc.M213251200
Submitted on December 30, 2002
Revised on May 10, 2003
Accepted on May 13, 2003

Deficient regulation of DNA double-strand break repair in fanconi anemia fibroblasts

Sarah L. Donahue, Richard Lundberg, Rachel Saplis, and Colin Campbell

Pharmacology, University of Minnesota, Minneapolis, MN 55455

Corresponding Author: dona0054{at}tc.umn.edu

Fibroblasts from patients with Fanconi anemia (FA) display genomic instability, hypersensitivity to DNA crosslinking agents, and deficient DNA end-joining. Fibroblasts from two FA patients of unidentified complementation group also have significantly increased cellular homologous recombination (HR) activity. Results described herein show that HR activity levels in patient-derived FA fibroblasts of groups A, C, and G were 10-fold greater than those seen in normal fibroblasts. In contrast, HR activity in group D2 fibroblasts was identical to that of normal cells. Western blot analysis revealed that RAD51 protein was elevated 10-fold above normal in group A, C, and G fibroblasts, but was not altered in D2 fibroblasts. HR activity levels in these former cells could be restored to near-normal levels by electroporation with an anti-RAD51 antibody, while similar treatment of normal and complementation group D2 fibroblasts had no effect. These findings are consistent with a model in which FA proteins function to coordinate DNA double-strand break repair activity by regulating both recombinational and non-recombinational DNA repair. Interestingly, whereas positive regulation of DNA end-joining requires the combined presence of all FA proteins thus far tested, suppression of HR, which is minimally dependent on the FANCA, FANCC and FANCG proteins, does not require FANCD2.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
J. M. Hinz, P. B. Nham, S. S. Urbin, I. M. Jones, and L. H. Thompson
Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis
Nucleic Acids Res., June 28, 2007; 35(11): 3733 - 3740.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Taniguchi and A. D. D'Andrea
Molecular pathogenesis of Fanconi anemia: recent progress
Blood, June 1, 2006; 107(11): 4223 - 4233.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Sobeck, S. Stone, V. Costanzo, B. de Graaf, T. Reuter, J. de Winter, M. Wallisch, Y. Akkari, S. Olson, W. Wang, et al.
Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks
Mol. Cell. Biol., January 15, 2006; 26(2): 425 - 437.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. D. Kennedy and A. D. D'Andrea
The Fanconi Anemia/BRCA pathway: new faces in the crowd
Genes & Dev., December 15, 2005; 19(24): 2925 - 2940.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Nakanishi, Y.-G. Yang, A. J. Pierce, T. Taniguchi, M. Digweed, A. D. D'Andrea, Z.-Q. Wang, and M. Jasin
Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair
PNAS, January 25, 2005; 102(4): 1110 - 1115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. W. Freie, S. L. M. Ciccone, X. Li, P. A. Plett, C. M. Orschell, E. F. Srour, H. Hanenberg, D. Schindler, S.-H. Lee, and D. W. Clapp
A Role for the Fanconi Anemia C Protein in Maintaining the DNA Damage-induced G2 Checkpoint
J. Biol. Chem., December 3, 2004; 279(49): 50986 - 50993.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. L. Donahue and C. Campbell
A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts
Nucleic Acids Res., June 15, 2004; 32(10): 3248 - 3257.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.